TMS Co., Ltd. (TYO:4891)

Japan flag Japan · Delayed Price · Currency is JPY
99.00
0.00 (0.00%)
Aug 6, 2026, 1:24 PM JST
Market Cap4.51B -37.5%
Revenue (ttm)n/a
Net Income-700.90M
EPS-15.99
Shares Out 45.57M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume71,600
Open99.00
Previous Close99.00
Day's Range97.00 - 100.00
52-Week Range92.00 - 166.00
Beta0.51
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About TMS Co., Ltd.

TMS Co., Ltd. engages in the research and development, manufacture, and sale of drug products, quasi-drugs, drug substances, medical devices, and medical commodities. The company is developing TMS-007, a stachybotrys microspora triprenyl phenol (SMTP) congener with prothrombolytic and anti-inflammatory/antioxidative activities, which has completed Phase 2a clinical trials for acute ischemic stroke treatment; and TMS-008, an SMTP congener with anti-inflammatory/antioxidative activities under nonclinical development for inflammatory complications... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2005
Employees 18
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4891
Full Company Profile

Financial Performance

Financial Statements